Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists

BACKGROUND: Bronchodilators are used for managing the symptoms of chronic obstructive pulmonary disease (COPD) and minimizing the risk of hospitalization and readmission. Hospital readmission is predictive of morbidity and mortality. OBJECTIVE: The study objective was to compare all-cause readmissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollu, Vamsi, Guérin, Annie, Gauthier, Geneviève, Hiscock, Robert, Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332308/
https://www.ncbi.nlm.nih.gov/pubmed/27864792
http://dx.doi.org/10.1007/s40801-016-0097-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332308/
https://www.ncbi.nlm.nih.gov/pubmed/27864792
http://dx.doi.org/10.1007/s40801-016-0097-y

Ejemplares similares